Kohjin Bio CoTSE:177A -0.90%18 ROA % is 1.10% as of Mar. 2026, which is 89% below its 10-year median of 10.15. GuruFocus rates TSE:177A with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Kohjin Bio Co ranks better than 84.63% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Kohjin Bio Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円98 Mil.
Kohjin Bio Co's average Total Assets over the quarter that ended in Mar. 2026 was 円8,874 Mil. Therefore, Kohjin Bio Co's annualized ROA % for the quarter that ended in Mar. 2026 was 1.10%.
The historical rank and industry rank for Kohjin Bio Co's ROA % or its related term are showing as below:
TSE:177A'
s ROA % Range Over the Past 10 Years
Min: 2.79 Med: 10.15 Max: 14.15
Current: 2.81
During the past 5 years, Kohjin Bio Co's highest ROA % was 14.15%. The lowest was 2.79%. And the median was 10.15%.
TSE:177A's ROA % is ranked better than 84.63% of 1418
companies
in the Biotechnology industry
Industry Median: -32.87
vs TSE:177A: 2.81
Kohjin Bio Co (TSE:177A) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Kohjin Bio Co ROA % Related Terms
Kohjin Bio Co ROA % Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Kohjin Bio Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's ROA % distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Kohjin Bio Co (TSE:177A) has a ROA % of 1.10% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Kohjin Bio Co and its competitors. This is 89% below median its historical median of 10.15. Over the past decade, Kohjin Bio Co's ROA % has ranged from 2.79 to 14.15. According to the industry distribution chart, Kohjin Bio Co ranks #218 out of 1418 companies in the Biotechnology industry, placing it in the top 15.4%.
Is Kohjin Bio Co's ROA % too high?
Kohjin Bio Co's current ROA % of 1.10% is 89% below median its 10-year median of 10.15. Over the past 10 years, this metric has ranged from a low of 2.79 to a high of 14.15. Based on the distribution chart, Kohjin Bio Co ranks #218 out of 1418 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #218 out of 1418 companies for ROA %. This places Kohjin Bio Co in the top 15% of its industry — outperforming the majority of peers. Historically, Kohjin Bio Co's own ROA % has ranged from 2.79 to 14.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Kohjin Bio Co and its competitors. Kohjin Bio Co's current ROA % is 1.10%, which is 89% below median its own 10-year median of 10.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current ROA % of 1.10%. The current ROA % is 1.10%, which is 89% below median its 10-year median of 10.15. Kohjin Bio Co's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current ROA % is 1.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
18GF Score
Get the complete analysis for TSE:177A
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 